WALTHAM, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing life-transforming therapeutics for ...
It's one of the most emotional battles in Final Fantasy 7 Rebirth: Barret vs. Dyne (Image via Square Enix) Long-time fans of FF7 knew that you’d have to beat Dyne in Final Fantasy 7 Rebirth.
The investigational therapy DYNE-101 worked as expected and led to functional improvements for people with myotonic dystrophy type 1 (DM1) in a clinical trial, according to an update from developer ...
Dyne Plots Path for Rare Muscle Disease Candidate Dyne Therapeutics also provided an encouraging program update at JPM25 on Wednesday, giving what Jefferies analysts call a “bar for success” that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results